Additional research data reveals a new understanding of how bergenin inhibits the growth of blood vessels in cervical carcinoma cells by affecting various proteins involved in blood vessel formation, such as Galectin-3 and MMP-9. The gene discussed is MMP9; the disease is cervical carcinoma.